Allogeneic Cell-Mediated and Cytokine-Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

Allogeneic Cell-Mediated and Cytokine-Activated Immunotherapy for Malignant Lymphoma at the Stage of Minimal Residual Disease After Autologous Stem Cell Transplantation

Published:1998-11 Issue:6 Volume:21 Page:447-453
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:Journal of Immunotherapy

Author:

Or Reuven,Ackerstein Aliza,Nagler Arnon,Amar Avraham,Naparstek Elizabeth,Varadi Gabor,Kapelushnik Joseph,Samuel Simcha,Pugatsch Thea,Brautbar Chaim,Slavin Shimon

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial;Journal of Clinical Oncology;2015-04-10

2. Adoptive immunotherapy with polyclonal T cells and natural killer cells for hematological malignancies: current status and future prospects;International Journal of Hematologic Oncology;2013-08

3. Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients;Blood;2011-01-20

4. Immunotherapy in high-risk chemotherapy-resistant patients with metastatic solid tumors and hematological malignancies using intentionally mismatched donor lymphocytes activated with rIL-2: a phase I study;Cancer Immunology, Immunotherapy;2010-06-20

5. Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma;Cancer;2010-02-15